Pharmacologic modulation of RNA splicing enhances anti-tumor immunity-Reference-Cited by-同舟云学术

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Published:2021-07 Issue:15 Volume:184 Page:4032-4047.e31
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Lu Sydney X.,De Neef Emma,Thomas James D.,Sabio Erich,Rousseau Benoit,Gigoux Mathieu,Knorr David A.,Greenbaum Benjamin,Elhanati Yuval,Hogg Simon J.,Chow Andrew,Ghosh Arnab,Xie Abigail,Zamarin Dmitriy,Cui Daniel,Erickson Caroline,Singer Michael,Cho Hana,Wang Eric,Lu Bin,Durham Benjamin H.,Shah Harshal,Chowell Diego,Gabel Austin M.,Shen Yudao,Liu Jing,Jin Jian,Rhodes Matthew C.,Taylor Richard E.,Molina Henrik,Wolchok Jedd D.,Merghoub Taha,Diaz Luis A.,Abdel-Wahab Omar,Bradley Robert K.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference49 articles.

1. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction;Abelin;Immunity,2017

2. TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma;Bertrand;Nat. Commun.,2017

3. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models;Chan-Penebre;Nat. Chem. Biol.,2015

4. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses;De Bruijn;Eur. J. Immunol.,1991

5. Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides;De Silva;J. Immunol.,1999

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide;Genes & Genomics;2024-09-13

2. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04

3. The roles and mechanisms of coding and noncoding RNA variations in cancer;Experimental & Molecular Medicine;2024-09-02

4. A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer;Cell Chemical Biology;2024-09

5. Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization;Journal of Cellular Physiology;2024-08-16